OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Yi Zhu, Tamar Tchkonia, Heike Fuhrmann‐Stroissnigg, et al.
Aging Cell (2015) Vol. 15, Iss. 3, pp. 428-435
Open Access | Times Cited: 917

Showing 1-25 of 917 citing articles:

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson, et al.
Cell Death and Differentiation (2018) Vol. 25, Iss. 3, pp. 486-541
Open Access | Times Cited: 5295

Hallmarks of aging: An expanding universe
Carlos López‐Otín, Marı́a A. Blasco, Linda Partridge, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 243-278
Open Access | Times Cited: 2710

Senescence in Health and Disease
Shenghui He, Norman E. Sharpless
Cell (2017) Vol. 169, Iss. 6, pp. 1000-1011
Open Access | Times Cited: 1430

Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Ok Hee Jeon, Chaekyu Kim, Remi-Martin Laberge, et al.
Nature Medicine (2017) Vol. 23, Iss. 6, pp. 775-781
Open Access | Times Cited: 1249

Cellular senescence mediates fibrotic pulmonary disease
Marissa J. Schafer, Thomas A. White, Koji Iijima, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 1230

Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Lars Larsson, Hans Degens, Meishan Li, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 427-511
Open Access | Times Cited: 1190

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1127

Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Tyler J. Bussian, Asef Aziz, Charlton F. Meyer, et al.
Nature (2018) Vol. 562, Iss. 7728, pp. 578-582
Open Access | Times Cited: 1032

Senescent cells: an emerging target for diseases of ageing
Bennett G. Childs, Martina Gluscevic, Darren J. Baker, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 10, pp. 718-735
Open Access | Times Cited: 1013

Cellular Senescence: Aging, Cancer, and Injury
Arianna Calcinotto, Jaskaren Kohli, Elena Zagato, et al.
Physiological Reviews (2019) Vol. 99, Iss. 2, pp. 1047-1078
Open Access | Times Cited: 956

Targeting cellular senescence prevents age-related bone loss in mice
Joshua N. Farr, Ming Xu, Megan Weivoda, et al.
Nature Medicine (2017) Vol. 23, Iss. 9, pp. 1072-1079
Open Access | Times Cited: 932

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Jamie N. Justice, Anoop M. Nambiar, Tamar Tchkonia, et al.
EBioMedicine (2019) Vol. 40, pp. 554-563
Open Access | Times Cited: 932

Cellular Senescence: A Translational Perspective
James L. Kirkland, Tamar Tchkonia
EBioMedicine (2017) Vol. 21, pp. 21-28
Open Access | Times Cited: 841

Inflammaging and ‘Garb-aging’
Claudio Franceschi, Paolo Garagnani, Giovanni Vitale, et al.
Trends in Endocrinology and Metabolism (2016) Vol. 28, Iss. 3, pp. 199-212
Open Access | Times Cited: 804

Senolytic drugs: from discovery to translation
James L. Kirkland, Tamar Tchkonia
Journal of Internal Medicine (2020) Vol. 288, Iss. 5, pp. 518-536
Open Access | Times Cited: 775

Fisetin is a senotherapeutic that extends health and lifespan
Matthew J. Yousefzadeh, Yi Zhu, Sara J. McGowan, et al.
EBioMedicine (2018) Vol. 36, pp. 18-28
Open Access | Times Cited: 756

Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Jun Guo, Xiuqing Huang, Lin Dou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 690

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies
Suowen Xu, Iqra Ilyas, Peter J. Little, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 924-967
Open Access | Times Cited: 667

Mechanisms and functions of cellular senescence
Nicolás Herranz, Jesús Gil
Journal of Clinical Investigation (2018) Vol. 128, Iss. 4, pp. 1238-1246
Open Access | Times Cited: 666

Unmasking senescence: context-dependent effects of SASP in cancer
Douglas V. Faget, Qihao Ren, Sheila A. Stewart
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 439-453
Closed Access | Times Cited: 647

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
Carolyn M Roos, Bin Zhang, Allyson K. Palmer, et al.
Aging Cell (2016) Vol. 15, Iss. 5, pp. 973-977
Open Access | Times Cited: 643

Cellular senescence and senolytics: the path to the clinic
Selim Chaib, Tamar Tchkonia, James L. Kirkland
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1556-1568
Open Access | Times Cited: 626

Cellular senescence: the good, the bad and the unknown
Weijun Huang, LaTonya J. Hickson, Alfonso Eirin, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 10, pp. 611-627
Open Access | Times Cited: 601

New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463
Yi Zhu, Ewald J. Doornebal, Tamar Pirtskhalava, et al.
Aging (2017) Vol. 9, Iss. 3, pp. 955-963
Open Access | Times Cited: 594

Page 1 - Next Page

Scroll to top